AVT lecturer and IQVIA Throught Leader Sarah Rickwood delve into pharmaceutical launch dynamics, especially post-pandemic, stressing regional variations and the importance of understanding local health systems. It highlights the crucial role of interactive engagement, showcasing higher levels in Excellent launches, particularly outside Europe. The Three Pillars of Post-Pandemic Launch Excellence are introduced, advocating for patient-centric approaches, strategic health system partnerships, and integrated evidence strategies. Early local investment is recommended to address system challenges effectively. Collaborations with health systems are seen as crucial for success, with examples demonstrating improved efficiency and outcomes. Future challenges include increasing demands on health systems and complex therapies, necessitating a comprehensive strategy to ensure launch success amidst industry changes.